News for Bristol-Myers Squibb Company (BMY)

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

We recently compiled a list of the 14 Best Performing Dividend Stocks To Buy Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other...

[url="]Agilent Technologies Inc.[/url] (NYSE: A) today announced its [url="]PD-L1 IHC 28-8 pharmDx[/url] kit has received two new companion diagnostic indicati

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now.

Bristol-Myers Squibb (BMY) stock in focus as psoriasis drug Sotyktu shows promising results in treating psoriatic arthritis in a Phase 3 trial. Read more here.

[url="]Bristol Myers Squibb[/url] (NYSE:BMY) today announced positive data from the pivotal Phase 3 POETYK PsA-2 trial (IM011-055) evaluating the efficacy and

Dividend stocks have taken a backseat in the market as technology and AI-driven equities have soared to record highs.

Investors with a lot of money to spend have taken a bearish stance on Bristol-Myers Squibb BMY. And retail traders should know. We noticed this today when the...

We're capping off a busy week of trades with another trim.

We recently published a list of Jim Cramer’s Latest Portfolio: Top 10 Stocks to Watch.

Bristol Myers Squibb (BMY) concluded the recent trading session at $60.18, signifying a +0.6% move from its prior day's close.

We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires.

Although new U.S. tariffs on Canada, Mexico, and China are putting pressure on markets, investors are shifting toward defensive positions amid economic uncertainty.

Bristol-Myers Squibb Company (NYSE:BMY) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ETCompany ParticipantsAdam Lenkowsky - Executive...

Ongoing strategic partnership advances joint pipeline in neurodegeneration researchEvotec receives a $20 million payment to further progress research HAMBURG, D

[url="]Bristol Myers Squibb[/url] (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per shar

Bristol-Myers Squibb (BMY) announces a $0.62 quarterly dividend with a 4.14% yield.

Strengths: Innovative AOC platform and robust pipeline with potential for significant market impact.Weaknesses: Lack of commercialization experience and high R